1,8-DIHYDROXY-4,5-DINITROANTHRAQUINONE, 95%, 50g

(S)-4-(6-(3,5-Dimethylisoxazol-4-yl)-1-(1-(pyridin-2-yl)ethyl)-1H-pyrrolo[3,2-b]pyridin-3-yl)benzoic acid, 98.00%, 25mg

2'-Bromo-5'-phenyl-1,1':3',1''-terphenyl>98.0%(GC)1g

(2-(Pyrrolidin-1-yl)pyridin-3-yl)methanamine, 95.0%, 10g

Metil-beta-ciclodestrina, minimo 98%, 1 g, confezione in vetro

Benzyl 6-bromo-5-methoxypyridine-3-carboxylate, 95%, 500mg

3,5-Dichloro-4-iodobenzoic acid, 95+%, 1g

6-Nitrobenzo[b]thiophene 1,1-dioxide, 95.0%, 25mg

5-Ethyl-3-hydroxy-4-methyl-2(5H)-furanone>97.0%(GC)(T)25g

(4-Formyl-5-hydroxy-6-methylpyridin-3-yl)methyl dihydrogen phosphate hydrate, 98.0%, 1g

1-Bromo-3-(isopropylsulfonyl)benzene, 95.0%, 10g

Ethyl 2-vinyloxazole-4-carboxylate, 95% mix TBC as stabilizer, 100g

4'-Bromo-3-iodobenzophenone, 97.0%, 1g